Atlas Energy Corp. (CANSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Atlas Energy Corp. (CANSF) trades at $0.10 with AI Score 44/100 (Grade C). Atlas Energy Corp. develops and sells plant-derived ingredients for various industries, including consumer care and pharmaceuticals. Market cap: $36.98M, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for CANSF: CANSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CANSF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CANSF: the 1 perspectives are evenly split.
How is this calculated? →Atlas Energy Corp. (CANSF) Healthcare & Pipeline Overview
Atlas Energy Corp., operating in the specialty and generic drug manufacturing sector, focuses on developing and commercializing plant-derived ingredients. With a partnership with Laurus Labs, the company targets the consumer care, food and beverage, and pharmaceutical markets, primarily within the United States, while maintaining a relatively small operational scale.
What Is the Investment Thesis for CANSF?
Atlas Energy Corp. presents a high-risk, high-reward investment opportunity within the biotechnology sector. The company's partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients could drive future revenue growth. However, the company's negative P/E ratio of -0.43 and negative profit margin of -39.1% indicate significant financial challenges. The high beta of 4.86 suggests extreme volatility compared to the market. Successful commercialization of its plant-derived ingredients and APIs is critical for achieving profitability. Investors should carefully consider the risks associated with the company's financial performance and market volatility before investing.
Based on FMP financials and quantitative analysis
CANSF Key Highlights
- Market capitalization of $36.98M indicates a micro-cap company with potential for high growth but also significant risk.
- Negative P/E ratio of -0.43 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Gross margin of 86.6% suggests strong pricing power and efficient production of plant-derived ingredients.
- Profit margin of -39.1% highlights the need for improved cost management and increased sales volume to achieve profitability.
- Beta of 4.86 indicates high volatility, making the stock susceptible to significant price swings based on market sentiment.
Who Are CANSF's Competitors?
CANSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CXXIF C21 Investments Inc. | $0.27 | +12.43% | $32.52M | 47 |
| ELIXF Elixxer Ltd. | $0.03 | +0.00% | $23.35M | 48 |
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CANSF's Key Strengths?
- Partnership with Laurus Labs for API development.
- High gross margin of 86.6%.
- Focus on plant-derived ingredients, aligning with consumer trends.
- Niche market focus in consumer care, food and beverage, and pharmaceuticals.
What Are CANSF's Weaknesses?
- Negative profit margin of -39.1%.
- Small market capitalization of $36.98M.
- High beta of 4.86, indicating significant volatility.
- Limited geographic presence, primarily in the United States.
What Could Drive CANSF Stock Higher?
- Potential for new partnerships or licensing agreements to expand product offerings.
- Commercialization of new active pharmaceutical ingredients (APIs) developed in partnership with Laurus Labs.
- Expansion of market reach within the consumer care, food and beverage, and pharmaceutical industries.
What Are the Key Risks for CANSF?
- Negative return on equity (-9.2%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Negative profit margin and financial instability.
- Intense competition in the specialty and generic drug manufacturing industry.
- Regulatory hurdles and compliance challenges.
- Delays or failures in API development and commercialization.
- High beta indicating significant market volatility.
What Are the Growth Opportunities for CANSF?
- Expansion of API Portfolio: Atlas Energy Corp.'s partnership with Laurus Labs provides a strong foundation for expanding its portfolio of active pharmaceutical ingredients. The global API market is projected to reach $297.4 billion by 2028, offering significant revenue potential. Successful development and commercialization of new APIs can drive substantial growth for Atlas Energy Corp. over the next 3-5 years.
- Penetration of Consumer Care Market: The market for plant-derived ingredients in consumer care products is growing due to increasing consumer demand for natural and sustainable products. Atlas Energy Corp. can capitalize on this trend by developing and marketing innovative ingredients for skincare, cosmetics, and personal care products. This market segment is expected to grow at a CAGR of 5-7% over the next 5 years.
- Strategic Partnerships and Licensing Agreements: Atlas Energy Corp. can pursue additional strategic partnerships and licensing agreements to expand its product offerings and market reach. Collaborating with other companies in the pharmaceutical, food and beverage, and consumer care industries can accelerate growth and reduce risk. These partnerships could be established within the next 2-3 years.
- Geographic Expansion: While currently focused on the United States, Atlas Energy Corp. can explore opportunities to expand its geographic presence into other markets, such as Europe and Asia. These regions offer significant growth potential for plant-derived ingredients and APIs. Geographic expansion can be pursued within the next 3-5 years.
- Development of Novel Delivery Systems: Investing in the development of novel delivery systems for its plant-derived ingredients and APIs can enhance their efficacy and bioavailability. This can create a competitive advantage and attract new customers. The market for advanced drug delivery systems is expected to grow at a CAGR of 8-10% over the next 5 years.
What Opportunities Does CANSF Have?
- Expansion of API portfolio through Laurus Labs partnership.
- Penetration of the growing market for plant-derived ingredients in consumer care.
- Strategic partnerships and licensing agreements to expand product offerings.
- Geographic expansion into new markets, such as Europe and Asia.
What Threats Does CANSF Face?
- Intense competition in the specialty and generic drug manufacturing industry.
- Pricing pressures and rising R&D costs.
- Stringent regulatory requirements and compliance challenges.
- Potential delays or failures in API development and commercialization.
What Are CANSF's Competitive Advantages?
- Proprietary plant-derived ingredient formulations.
- Partnership with Laurus Labs for API development and commercialization.
- Focus on niche markets within the consumer care, food and beverage, and pharmaceutical industries.
What Does CANSF Do?
Atlas Energy Corp., formerly known as Willow Biosciences Inc., is a biotechnology company founded in 2019 and headquartered in Calgary, Canada. The company specializes in developing, producing, and selling plant-derived ingredients. These ingredients cater to a diverse range of industries, including consumer care, food and beverage, and pharmaceuticals. Atlas Energy Corp. operates primarily in the United States, focusing on delivering specialized ingredients to meet the evolving demands of these sectors. A key aspect of Atlas Energy Corp.'s strategy is its licensing and development partnership with Laurus Labs. This collaboration aims to develop and commercialize active pharmaceutical ingredients (APIs) and other ingredients, enhancing the company's capabilities in the pharmaceutical market. The company changed its name to Atlas Energy Corp. in June 2025, marking a new chapter in its corporate evolution. With a small team of 19 employees, Atlas Energy Corp. focuses on innovation and strategic partnerships to expand its market reach and product offerings.
What Products and Services Does CANSF Offer?
- Develops plant-derived ingredients for various industries.
- Produces plant-derived ingredients.
- Sells plant-derived ingredients in the United States.
- Partners with Laurus Labs to develop active pharmaceutical ingredients (APIs).
- Commercializes active pharmaceutical ingredients and other ingredients.
- Focuses on the consumer care, food and beverage, and pharmaceutical markets.
How Does CANSF Make Money?
- Develops and manufactures plant-derived ingredients.
- Generates revenue through the sale of these ingredients to consumer care, food and beverage, and pharmaceutical companies.
- Collaborates with Laurus Labs through licensing and development partnerships to expand its product offerings.
What Industry Does CANSF Operate In?
Atlas Energy Corp. operates within the specialty and generic drug manufacturing industry, a sector characterized by intense competition and stringent regulatory requirements. The market is driven by the increasing demand for affordable healthcare solutions and the expiration of patents on blockbuster drugs. Companies like Atlas Energy Corp. focus on niche markets and specialized ingredients to differentiate themselves. The industry faces challenges such as pricing pressures, rising R&D costs, and the need for continuous innovation. Atlas Energy Corp.'s success depends on its ability to effectively commercialize its plant-derived ingredients and APIs in a competitive landscape that includes companies such as CBSTF (Cannabics Pharmaceuticals Inc.).
Who Are CANSF's Key Customers?
- Consumer care product manufacturers.
- Food and beverage companies.
- Pharmaceutical companies.
How Atlas Energy Corp. Is Valued
Atlas Energy Corp. carries a market capitalization of $36.98M, placing it in the micro-cap category. Relative to its peer group, CANSF's quantitative score of 44/100 is below the peer average of 60/100.
Company Profile
Atlas Energy Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Calgary, CA. The company is led by CEO Mark Alan Hodgson. CANSF has traded publicly since 2021.
ROE -9%Key Financial Metrics
Return on equity for Atlas Energy Corp. stands at -9.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -2.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -43.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 32.23 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -94.8%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 2/9Financial Health
Atlas Energy Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 40.78 places it in the safe zone, indicating low near-term bankruptcy risk.
CANSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests those in the know see value, a classic bullish signal.
- Community chatter highlights potential upside from upcoming projects, fueling positive sentiment.
- The general market perception seems to be shifting positively, with more mentions of potential growth.
- Bullish community members are emphasizing the company's strategic positioning in a growing sector.
Bear Case
- Lack of news flow recently has created uncertainty among some investors.
- Bearish community viewpoints focus on potential regulatory hurdles impacting future operations.
- Concerns exist regarding the company's ability to scale effectively, a common worry.
- Market perception includes skepticism about the company's long-term competitive advantage, a key bearish argument.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CANSF Latest News
No recent news available for CANSF.
CANSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CANSF.
Price Targets
Wall Street price target analysis for CANSF.
CANSF MoonshotScore
What does this score mean?
The MoonshotScore rates CANSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Mark Alan Hodgson
CEO
Mark Alan Hodgson serves as the CEO of Atlas Energy Corp. His background includes experience in managing and leading biotechnology companies. He has a proven track record in strategic planning, business development, and operational management. Hodgson's expertise lies in driving innovation and growth within the healthcare sector. His leadership is focused on expanding Atlas Energy Corp.'s market presence and enhancing its product offerings.
Track Record: Under Mark Alan Hodgson's leadership, Atlas Energy Corp. has focused on strengthening its partnership with Laurus Labs and expanding its portfolio of plant-derived ingredients. He has overseen the company's transition from Willow Biosciences Inc. to Atlas Energy Corp. and has been instrumental in driving the company's strategic direction. His focus is on achieving sustainable growth and profitability.
CANSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Atlas Energy Corp. may not meet the minimum financial or reporting standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks due to less stringent regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure and transparency.
- Potential for higher price volatility due to lower trading volumes.
- Increased risk of fraud or manipulation due to less regulatory oversight.
- Difficulty in obtaining accurate and timely information about the company.
- Potential for delisting or trading suspensions.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Review any available news articles or press releases about the company.
- Consult with a qualified financial advisor.
- Understand the risks associated with investing in OTC stocks.
- Check for any regulatory actions or legal proceedings involving the company.
- Partnership with Laurus Labs suggests some level of external validation.
- Focus on developing plant-derived ingredients aligns with market trends.
- Company has been in operation since 2019.
- Presence of a CEO and management team.
What Investors Ask About Atlas Energy Corp. (CANSF) — Healthcare
What does Atlas Energy Corp. do?
Atlas Energy Corp. is a biotechnology company that focuses on developing, producing, and selling plant-derived ingredients. These ingredients are used in various industries, including consumer care, food and beverage, and pharmaceuticals. The company also has a strategic partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients (APIs), expanding its capabilities in the healthcare sector. Atlas Energy Corp. aims to provide innovative and sustainable solutions to meet the evolving demands of its target markets.
What do analysts say about CANSF stock?
Currently, there is no available analyst coverage for CANSF stock. Given its micro-cap status and OTC listing, the stock may not be widely followed by analysts. Investors should conduct their own thorough research and consider the company's financial performance, growth potential, and risk factors before making any investment decisions. Key valuation metrics to consider include the company's P/E ratio, profit margin, and revenue growth.
What are the main risks for CANSF?
Atlas Energy Corp. faces several key risks, including its negative profit margin and financial instability. The company operates in a highly competitive industry with stringent regulatory requirements. Delays or failures in API development and commercialization could significantly impact its growth prospects. The high beta of 4.86 indicates significant market volatility, making the stock susceptible to price swings. Investors should carefully assess these risks before investing in CANSF.
What are the key factors to evaluate for CANSF?
Atlas Energy Corp. (CANSF) holds an AI score of 44/100 (low). Not financial advice.
How frequently does CANSF data refresh on this page?
CANSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CANSF's recent stock price performance?
Atlas Energy Corp. (CANSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Partnership with Laurus Labs for API development. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CANSF overvalued or undervalued right now?
Valuing Atlas Energy Corp. (CANSF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CANSF?
Before investing in Atlas Energy Corp. (CANSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on OTC-listed companies.
- Financial data based on available information and may not be comprehensive.